| Document |
Document Title |
|
WO/2009/005110A2 |
There is provided a halogen-containing organosulfur compound having an excellent controlling effect on arthropod pests represented by the formula (I): wherein, m represents 0, 1 or 2, n represents 0, 1 or 2, A represents optionally subst...
|
|
WO/2008/153159A1 |
It is intended to provide a novel amine compound represented by the following general formula (I), a pharmaceutically acceptable acid addition salt thereof, a hydrate thereof or a solvate thereof, which has an excellent peripheral blood ...
|
|
WO/2008/148853A1 |
The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein: each R1 is independently selected from the group consisting of Cl, Br, CH3 and CF3; X is carbon or nitroge...
|
|
WO/2008/142100A1 |
The invention relates to an improved method for producing carbonate-terminated urethanes using isocyanates. The method according to the invention is characterized by high yields with no phenol being produced as a secondary component.
|
|
WO/2008/143293A1 |
Disclosed is a carbonate compound represented by the following general formula (I) (In the formula, R represents an alkyl group having 1-6 carbon atoms or an alkoxyalkyl group having 1-6 carbon atoms.). This carbonate compound is useful,...
|
|
WO/2008/142097A2 |
The invention relates to an improved method for producing carbonate-terminated compounds using amines. The method according to the invention is characterized by high yields with no phenol being produced as a secondary component.
|
|
WO/2008/142101A1 |
The invention relates to an improved method for producing carbonate-terminated urethanes using di- or polyisocyanates. The method according to the invention is characterized by high yields with no phenol being produced as a secondary com...
|
|
WO/2008/139315A2 |
Polycyclic aromatic compounds of formula (I) having at least two conjugated aromatic rings at least one of which has a substituent comprising a cyclic carbonate group can be used as sensitisers for cationic photoinitiators, especially io...
|
|
WO/2008/139079A2 |
The invention relates to a conjugated method for the production of ω-amino-alkanoic acids and polyol carbonates from a natural monounsaturated fatty acid, comprising the following zones: I) zone for methanolysis of a natural oil contain...
|
|
WO/2008/138639A1 |
This invention relates to novel substituted phenylamino-benzene compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper- proliferative and/or angiogenesis disorde...
|
|
WO/2008/136378A1 |
Disclosed is a compound represented by the following general formula: (wherein R1 represents a hydrogen atom or the like; R2 represents an optionally substituted alkyl or aryl group or the like; R3 and R4 may be the same or different and...
|
|
WO/2008/132474A1 |
A process for the production of cyclic carbonates comprising contacting an epoxide with carbon dioxide in the presence of a dimeric aluminium(salen) catalyst, and a co-catalyst capable of supplying Y-, where Y is selected from Cl, Br and...
|
|
WO/2008/128956A1 |
The invention relates to a process for preparing an 1,2-alkylene carbonate comprising: i)contacting carbon dioxide, an 1,2-alkylene oxide and a carbonation catalyst in a reactor to produce a crude reactor effluent containing carbon dioxi...
|
|
WO/2008/124878A1 |
The present invention relates to non-steroidal compounds useful in the treatment of inflammatory conditions and pharmaceutical compositions comprising them. A representative example of these compounds is formula (III).
|
|
WO/2008/122620A1 |
The invention relates to a compound of the formula (I) in which: R1, R2 and R3 are independently a methoxy group optionally substituted by one or more fluorine atoms; R4 is a hydrogen atom; R5 and R6 are identical and each represent a hy...
|
|
WO/2008/111414A1 |
Disclosed is a catalyst composition comprising a fluoride of iron or cobalt and a nitrogenated heterocyclic compound represented by the general formula (1A) or (1B). (1A) or (1B) wherein R1 and R2 independently represent a substituted or...
|
|
WO/2008/110278A2 |
The use of N2-phenylamidines of general formula (I) as herbicides is disclosed. In said general formula (I) R2, R3, R4, R5 and R6 are various groups and A is a bond or various single- or multi-atom bridge elements.
|
|
WO/2008/111282A1 |
Disclosed is a hydrotalcite surface-immobilized metal particle catalyst, which is obtained by immobilizing at least one metal selected from Cu, Ag and Au, in the form of particles, on a hydrotalcite surface. Also disclosed is a method fo...
|
|
WO/2008/108429A1 |
There are provided [1] method of retaining the quality of 2-methyl-3-(3,4-methylenedioxyphenyl)propanal containing 50 to 3000 ppm of 1-acetyl-3,4-methylenedioxybenzene which is useful as a perfume; [2] process for producing the 2-methyl-...
|
|
WO/2008/099882A1 |
Disclosed are: (1) a method for producing 2-methyl-3-(3,4-methylenedioxyphenyl)propanal, which comprises the steps of producing a reaction mixture containing 1-actoxy-2-methyl-3-(3,4-methylenedioxyphenyl)-1-propene by a process for react...
|
|
WO/2008/098375A1 |
The invention emcompasses polyunsaturated fatty acid monoglycerides and derivatives thereof, having the formulae (I), (II), (III) and (IV), pharmaceutically acceptable salts thereof, compositions thereof and processes of preparing said c...
|
|
WO/2008/098077A2 |
The invention provides compounds of Formula (I) : wherein R1 and R2 have any of the values or specific values defined herein, as well as composition comprising such compounds and therapeutic methods comprising the administration of such ...
|
|
WO/2008/095328A1 |
A kind of hydrochloric piperphentonamine freeze-dried powder injection and their preparation methods. The injection is formed by freezing and drying with one portion of hydrochloric piperphentonam- ine, 2.5-30 portions of excipients and ...
|
|
WO/2008/090046A1 |
The present invention provides a novel process for the preparation of lactone daerivatives of the formula (1) which are key intermediates in the preparation of 1-(2-deoxy-2-fluoro-2-C-methyl- b -D-ribofuranosyl)cytosine (2) a compound th...
|
|
WO/2008/090731A1 |
Disclosed is a method for producing a 2-nitroimidazole derivative having an acyclic sugar chain in a side chain which is suitable for production of a derivative having a radioisotope. Specifically disclosed is a method for producing 1-(1...
|
|
WO/2008/078762A1 |
Disclosed are: a study on the synthesis of a novel N-(2-aminophenyl)benzamide derivative having an urea structure and represented by the general formula (1); and the utilization of the pharmacological activity of the derivative. A compou...
|
|
WO/2008/075353A1 |
The present invention relates to sulfonamide derivatives of formula (I) (wherein R1, R2, R3, R3', R4and R5are as defined in the claims), to pharmaceutical compositions comprising the same, and to uses thereof. Compounds of the invention ...
|
|
WO/2008/074693A2 |
The present invention provides a novel process for the preparation of 3,5-di-O- acyl-2-fluoro-2-C-methyl-D-ribono-g-lactone derivatives of formula (2) which are key intermediates in the preparation of 1-(2-deoxy-2-fluoro-2-C-methyl-β-D-...
|
|
WO/2008/075545A1 |
Disclosed is a novel fluorine-containing compound which enables to obtain a fluorine-containing polymer having high transparency, good heat resistance and appropriate flexibility. Also disclosed is a fluorine-containing polymer containin...
|
|
WO/2008/068423A2 |
The invention relates to compounds having the formula (I), wherein A represents: a substituted or non substituted alkylene (C1-C6) group; a Formula (II) group having m = O, 1 or 2 and p = 0 or 1; R1 represents hydrogen or a (C1 -C2 )alky...
|
|
WO/2008/067911A1 |
The invention relates to new compounds of the formula (I) in which W, X, Y, Z and CKE have the meanings given above, to a plurality of processes and intermediates for their preparation and to their use as pesticides and/or herbicides, an...
|
|
WO/2008/064827A2 |
The present invention relates to a process for preparing nebivolol and, more particularly, to a process for preparing d-nebivolol and its enantiomer /-nebivolol or acid addition salts thereof starting from commercially available or easil...
|
|
WO/2008/061871A1 |
The present invention relates to ketomethionine ketals or hemiketals and their derivatives and also their preparation and their use as fodder additives, in particular for the nutrition of ruminants.
|
|
WO/2008/061308A1 |
The present invention relates to protein tyrosine phosphatase (PTP) modulators, in particular PTP inhibitors and their use in the treatment or prophylaxis of disorders modulated by PTP such as cellular proliferation disorders; autoimmune...
|
|
WO/2008/059335A1 |
Compounds of Formula (I) that act as antagonists at the mu, kappa and/or delta opioid receptors and therefore useful in the treatment of diseases, conditions and/or disorders that benefit from such antagonism in animals are described her...
|
|
WO/2008/059841A1 |
Disclosed is a process for producing a 1-acyloxy-3-(3,4-methylenedioxyphenyl)-1-propene compound which is useful as an intermediate for the synthesis of an organic chemical substance or the like, in an industrially advantageous manner. T...
|
|
WO/2008/051244A2 |
The present invention is directed to compounds of formula (I): wherein R1 is selected from the group consisting of -C(O)R and (a), wherein R6 and R7 are independently selected from H, alkyl, cycloalkyl, heterocycloalkyl, heteroaryl or ar...
|
|
WO/2008/044667A1 |
An object of the present invention is to provide a STAT3/5 activation inhibitor. The present invention provides a STAT3/5 activation inhibitor containing an aromatic compound represented by the general formula or a salt thereof as an act...
|
|
WO/2008/043947A1 |
The invention relates to a method for the synthesis of cyclic acetals that comprises reacting at least one carbonyl-function compound selected from aldehydes, ketones and/or linear acetals, on a polyol in a concentrated aqueous solution ...
|
|
WO/2008/034685A1 |
The invention relates to a method of production of enantiomer-enriched alkylene carbonates (I), in particular (R)-propylene carbonate (I), by enantioselective enzymatic reduction of an O- substituted hydroxyacetone of type (II) and subse...
|
|
WO/2008/034265A1 |
An aqueous process for preparing alkylene carbonates from alkenes and carbon dioxide is described herein. The process comprises the reaction of alkenes with a bromine source, a base and carbon dioxide. The aqueous process can be rendered...
|
|
WO/2008/031864A1 |
A process for the preparation of an alkylene carbonate, said process comprising contacting the corresponding alkylene oxide with carbon dioxide in the presence of water and in the presence of a catalytic composition comprising an organic...
|
|
WO/2008/028953A1 |
A process for the preparation of an alkylene glycol, said process comprising reacting the corresponding alkylene carbonate with water in the presence of a catalyst, wherein the catalyst comprises bicarbonate as active phase, immobilised ...
|
|
WO/2008/023836A1 |
Disclosed is a process for the production of a benzaldehyde of the formula (II), which comprises the steps of: mixing a mixed solution (1) or (2) with water and an acid to prepare a mixed reaction solution, where the mixed solution (1) c...
|
|
WO/2008/022287A1 |
The present technology relates generally to the production of HMF-glycerin acetal, ethers, diethers, esters, and diesters derived therefrom, and aliphatic or aromatic polyester polymers derived therefrom. For example, HMF-glycerin acetal...
|
|
WO2007062158B1 |
The present disclosure relates to methods of preparation of compounds resulting from the reaction of levulinic esters and epoxidized unsaturated fatty acid esters. The compounds are useful as renewable biomass-based plasticizers for a va...
|
|
WO/2008/019690A1 |
The invention relates to novel compounds according to formula Ia and Ib; (Formula Ia and Ib) wherein A represents substituted or unsubstituted C1-10heteroaryl, C6-14aryl or C6- 10heterocycloalkylaryl; R1 is C1-6alkyl, C2-6alkenyl, C2-6al...
|
|
WO/2008/016677A2 |
Provided herein are deuterated amphetamines, processes of preparation and pharmaceutical compositions thereof. Also provided are methods of their use for the treatment and/or management of trauma associated with a terminal disease, a pos...
|
|
WO/2008/015231A1 |
A process for the preparation of an alkylene carbonate, said process comprising contacting the corresponding alkylene oxide with carbon dioxide in the presence of a metal salt immobilised on a solid support, wherein the metal salt compri...
|
|
WO/2008/016596A2 |
Pseudobase benzo[c]ρhenanthridines and the pharmaceutically acceptable salts thereof of Formula I (i) are provided herein. The variables R, Rj, R2, R3, and R4 are defined herein. Certain pseudobase benzo[c]phenanthridines provided herei...
|
